Litcius/Paper detail

The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study

Sho Sato, Takashi Ssuzuki, Takashi Chinen, Hironori Yamaguchi, Yusuke Suzuki, Nobukazu Hokamura, Zenichiro Saze, Koji Kono, Keita Takahashi, Fumiaki Yano, Chikara Kunisaki, Takashi Kosaka, Itaru Endo, Yasushi Ichikawa, Yutaka Miyawaki, Hiroshi Sato, Hideaki Shimada

2024International Journal of Clinical Oncology13 citationsDOI

Topics & Concepts

MedicineSurgical oncologyOncologyEsophageal cancerInternal medicineCohortCancerImmune checkpointImmunotherapyCancer Immunotherapy and BiomarkersEsophageal Cancer Research and TreatmentInflammatory Biomarkers in Disease Prognosis
The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study | Litcius